The Association between Body Mass Index (BMI) and Time in Range among Young Adults with Type 1 Diabetes: Data from the T1D Exchange QI Collaborative
S. Rompicherla1, M. Kamboj2, E. Cobry3, B. Frohnert3, A. Rewers3, M. Desimone4, D. Ferro5, S. Ogburn6, B. Mccann‐Crosby7, S. Phillips8,…
Ranking Of Important Factors in Recommending Diabetes Technology by Pediatric and Adult Endocrinologists
K. Cossen1, O. Ebekozien2, O. Odugbesan2, E. Ospelt2, S. Corathers3, D. Hansen4, M. Scott5, P. Mathias6, B. Adams7, J. Indyk8, C….
Race-ethnicity Mediated Bias in Recommending Technology: Does Implicit Bias Training Make a Difference?
O. Odugbesan1, A. Addala2, K. Gandhi3, N. Rioles1, N. Hawa Yayah Jones4, R. Izquierdo5, K. Cossen6, J. Schmitt7, S. Agarwal8,…
Diabetes Provider Bias to Recommending Diabetes Technology for Patients on Public Insurance in the United States
O. Odugbesan1, A. Mungmode1, N. Rioles1, D. Buckingham2, A. Grant3, R. Hopkins4, K. Cossen5, M. Scott6, P. Mathias7, B. Adams8,…
Inequities in Diabetes Device Use: Update from T1D Exchange Health Equity Project
O. Odugbesan1, A. Mungmode1, N. Rioles1, D. Buckingham2, M. Scott3, G. Nelson4, R. Hopkins5, A. Grant6, O. Ebekozien Background and…
Hybrid Closed Loop Systems and Glycemic Outcomes in Children and Adults with Type 1 Diabetes: Real World Evidence From U.S. Based Multi-Center Collaborative
D. Desalvo1, O. Ebekozien2, E. Ospelt2, M. Kamboj3, E. Cobry4, S. Polsky4, R. Izquierdo5, R. Mcdonough6, S. Ogburn7, C. Demeterco‐Berggren8, L….
Challenges of Transitioning to Telehealth During COVID-19
Background: We describe the utilization of telemedicine visits (video or telephone) across the type 1 diabetes (T1D) Exchange Quality Improvement Collaborative…
Health Outcomes in COVID-19 Positive Patients with T1D Using an Insulin Pump
Background and Aims: The use of continuous subcutaneous insulin infusion (CSII) has demonstrated fewer acute complications in patients with type 1…
CGM Usage and Health Outcomes among People with T1D and COVID-19
Background and Aims: Continuous glucose monitoring (CGM) improves glycemic control and reduces complications in patients with type 1 diabetes (T1D). This…
Real-time Continuous Glucose Monitoring (CGM) Versus Self-Monitoring of Blood Glucose in Type 1 Diabetes (T1D)
Background and Aims: The management of type 1 diabetes (T1D) involves strict glucose control to avoid acute complications. The use of…
